ARDS insider transaction filings
Aridis Pharmaceuticals, Inc. — 5 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-06-28. Screen ARDS transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for ARDS between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Aridis Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-06-28 | 4 | Windham-Bannister Susan Richards — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Jafri Hasan — Chief Medical Officer | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Patzer Eric — Director | Purchase (P): 714,286 @ $0.07 | EDGAR |
| 2024-06-28 | 4 | Truong Vu — CEO, Director | Purchase (P): 714,286 @ $0.07 | EDGAR |
| 2024-06-28 | 4 | HAMILTON JOHN F — Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aridis Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2024-06-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARDS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →